Guficap 70mg Injection
By Guficap
Rx
1ml Injection in a Vial

Composition
Caspofungin(70mg)

Manufacturer - Gufic Bioscience Ltd
37,1st Floor, Kamala Bhavan II, Swami Nityanand Road, Andheri (East), Mumbai - 400 069. (INDIA)

Expires on or after
April, 2026

liver
Caution should be exercised when using Bdcaspo 70mg Injection in patients with liver disease. It may be necessary to adjust the dose of the injection, therefore consulting your doctor is essential before starting the treatment. It is important to note that there is limited information on the use of Bdcaspo 70mg Injection in patients with severe liver disease.

kidney
Bdcaspo 70mg Injection is considered safe for patients with kidney disease, and no dosage adjustment is needed.

alcohol
Consult your doctor when consuming alcohol with Bdcaspo 70mg Injection.

driving
It is not clear how Bdcaspo 70mg Injection affects driving. If you have symptoms that impact focus and reaction time, avoid driving while using this injection.

pregnancy
Bdcaspo 70mg Injection may not be safe to use during pregnancy. Limited human studies indicate potential risks, with animal studies showing harm to the baby's development. Your doctor will assess benefits and risks before prescribing. Please consult your doctor before using.

breastfeeding
Bdcaspo 70mg Injection is likely safe during breastfeeding based on limited human data indicating low risk to the baby.
Habit Forming | No |
Chemical Class | Echinocandins |
Therapeutic Class | - |
Action Class | - |
₹4059
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024